James L. Reading

8.1k total citations · 1 hit paper
29 papers, 1.4k citations indexed

About

James L. Reading is a scholar working on Oncology, Immunology and Surgery. According to data from OpenAlex, James L. Reading has authored 29 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 12 papers in Immunology and 7 papers in Surgery. Recurrent topics in James L. Reading's work include Cancer Immunotherapy and Biomarkers (9 papers), Immunotherapy and Immune Responses (7 papers) and CAR-T cell therapy research (6 papers). James L. Reading is often cited by papers focused on Cancer Immunotherapy and Biomarkers (9 papers), Immunotherapy and Immune Responses (7 papers) and CAR-T cell therapy research (6 papers). James L. Reading collaborates with scholars based in United Kingdom, United States and Australia. James L. Reading's co-authors include Charles Swanton, Sergio A. Quezada, Nicholas McGranahan, Rachel Rosenthal, Kevin Litchfield, Hang Xu, Yien Ning Sophia Wong, Andrew Rowan, James Larkin and Samra Turajlic and has published in prestigious journals such as Nature Communications, Nature Genetics and Journal of Clinical Oncology.

In The Last Decade

James L. Reading

28 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis

2017 662 citations Samra Turajlic, Kevin Litchfield et al. The Lancet Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James L. Reading United Kingdom	14	698	543	391	272	263	29	1.4k
Rosario Alberto Caruso Italy	22	439 0.6×	440 0.8×	340 0.9×	362 1.3×	141 0.5×	89	1.4k
Julius Strauss United States	18	1.2k 1.7×	722 1.3×	349 0.9×	288 1.1×	127 0.5×	81	1.7k
Joan Somja Belgium	21	542 0.8×	397 0.7×	452 1.2×	199 0.7×	204 0.8×	56	1.5k
Hyo Jeong Kang South Korea	21	665 1.0×	354 0.7×	255 0.7×	270 1.0×	186 0.7×	86	1.4k
Lisa M. Cordes United States	20	1.2k 1.7×	522 1.0×	308 0.8×	412 1.5×	124 0.5×	105	1.6k
Hiroshi Nakagomi Japan	16	558 0.8×	435 0.8×	272 0.7×	162 0.6×	242 0.9×	58	1.2k
Xiang‐Ming Lao China	26	1.0k 1.4×	1.1k 1.9×	401 1.0×	295 1.1×	260 1.0×	56	2.1k
Natalja T. ter Haar Netherlands	26	677 1.0×	384 0.7×	700 1.8×	184 0.7×	545 2.1×	51	2.1k
Jun‐ichi Tamaru Japan	21	771 1.1×	224 0.4×	205 0.5×	227 0.8×	157 0.6×	108	1.5k
Javier Menárguez Spain	28	828 1.2×	338 0.6×	442 1.1×	190 0.7×	264 1.0×	68	2.2k

Countries citing papers authored by James L. Reading

Since Specialization

Citations

This map shows the geographic impact of James L. Reading's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James L. Reading with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James L. Reading more than expected).

Fields of papers citing papers by James L. Reading

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James L. Reading. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James L. Reading. The network helps show where James L. Reading may publish in the future.

Co-authorship network of co-authors of James L. Reading

This figure shows the co-authorship network connecting the top 25 collaborators of James L. Reading. A scholar is included among the top collaborators of James L. Reading based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James L. Reading. James L. Reading is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Qian, Danwen, Krupa Thakkar, Marcellus Augustine, et al.. (2024). A pan-cancer single-cell RNA-seq atlas of intratumoral B cells. Cancer Cell. 42(10). 1784–1797.e4. 16 indexed citations

Magness, Alastair, Emma Colliver, Katey S.S. Enfield, et al.. (2024). Deep cell phenotyping and spatial analysis of multiplexed imaging with TRACERx-PHLEX. Nature Communications. 15(1). 5135–5135. 2 indexed citations

Ung, Seng Kuong Anakin, Lukas Kalinke, Adam Pennycuick, et al.. (2023). 1032 Early remodelling of CD4 T cell differentiation in lung squamous carcinogenesis. SHILAP Revista de lepidopterología. A1139–A1139. 1 indexed citations

Reading, James L., Deborah R. Caswell, & Charles Swanton. (2023). Tumor heterogeneity impairs immunogenicity in mismatch repair deficient tumors. Nature Genetics. 55(10). 1610–1612. 4 indexed citations

Hwang, E. Shelley, James L. Reading, Jun Yu, et al.. (2023). Pre-cancer: From diagnosis to intervention opportunities. Cancer Cell. 41(4). 637–640. 1 indexed citations

Dijkstra, Krijn K., Roberto Vendramin, Robert E. Hynds, et al.. (2022). Abstract 692: Patient-derived co-cultures of TRACERx lung cancer organoids and autologous T-cells reveal heterogeneity in immune evasion between cancer subclones. Cancer Research. 82(12_Supplement). 692–692. 1 indexed citations

Litchfield, Kevin, James L. Reading, Emilia L. Lim, et al.. (2020). Escape from nonsense-mediated decay associates with anti-tumor immunogenicity. Nature Communications. 11(1). 3800–3800. 68 indexed citations

Sabbah, Shereen, Aaron Liew, Augustin Brooks, et al.. (2020). Autoreactive T cell profiles are altered following allogeneic islet transplantation with alemtuzumab induction and re-emerging phenotype is associated with graft function. American Journal of Transplantation. 21(3). 1027–1038. 5 indexed citations

Litchfield, Kevin, James L. Reading, Nicholas McGranahan, Sergio A. Quezada, & Charles Swanton. (2020). 1928O Meta-analysis of tumour and T cell intrinsic mechanisms of sensitization to checkpoint inhibition. Annals of Oncology. 31. S1092–S1092. 3 indexed citations

10.

Ramskov, Sofie, Theo Sturm, Annie Borch, et al.. (2019). HLA-C restricted neoepitopes contribute significantly to the immune recognition of cancer. Technical University of Denmark, DTU Orbit (Technical University of Denmark, DTU). 1 indexed citations

11.

Carty, Fiona, João Paulo Monteiro Carvalho Móri da Cunha, James L. Reading, et al.. (2018). Multipotent Adult Progenitor Cells Suppress T Cell Activation in In Vivo Models of Homeostatic Proliferation in a Prostaglandin E2-Dependent Manner. Frontiers in Immunology. 9. 645–645. 13 indexed citations

12.

Turajlic, Samra, Kevin Litchfield, Hang Xu, et al.. (2017). Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis. The Lancet Oncology. 18(8). 1009–1021. 662 indexed citations breakdown →

13.

Ghorani, Ehsan, Rachel Rosenthal, Nicholas McGranahan, et al.. (2017). Differential binding affinity of mutated peptides for MHC class I is a predictor of survival in advanced lung cancer and melanoma. Annals of Oncology. 29(1). 271–279. 96 indexed citations

14.

Reading, James L., Bart Vaes, Caroline Hull, et al.. (2015). Suppression of IL-7-dependent Effector T-cell Expansion by Multipotent Adult Progenitor Cells and PGE2. Molecular Therapy. 23(11). 1783–1793. 35 indexed citations

15.

Reading, James L., Jennie H. M. Yang, Shereen Sabbah, et al.. (2013). Clinical-Grade Multipotent Adult Progenitor Cells Durably Control Pathogenic T Cell Responses in Human Models of Transplantation and Autoimmunity. The Journal of Immunology. 190(9). 4542–4552. 56 indexed citations

16.

Reading, James L., Adrienne F. A. Meyers, & Annapurna Vyakarnam. (2012). Whey acidic proteins (WAPs). Current Opinion in HIV and AIDS. 7(2). 172–179. 6 indexed citations

17.

Alvarez, Raymond, et al.. (2011). WFDC1 expression identifies memory CD4 T- lymphocytes rendered vulnerable to cell-cell HIV-1 transfer by promoting intercellular adhesive junctions. Retrovirology. 8(1). 29–29. 12 indexed citations

18.

Aggarwal, Manisha, et al.. (2005). TRANSVERSE INCISION FOR LESSER METATARSOPHALANGEAL EXPOSURE. A WORKHORSE INCISION FOR THE FOREFOOT. 370–370.

19.

Hall, R., et al.. (1995). The persistence of bacille Calmette‐Guerin in the bladder after intravesical treatment for bladder cancer. British Journal of Urology. 75(2). 188–192. 56 indexed citations

20.

Reading, James L., R. Hall, & Mahesh Parmar. (1995). The application of a prognostic factor analysis for Ta.T1 bladder Cancer in routine urological practice. British Journal of Urology. 75(5). 604–607. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact